<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Walker DM</submitter><funding>NIDA NIH HHS</funding><funding>Substance Abuse and Mental Health Services Administration</funding><funding>National Institutes of Health</funding><pagination>209276</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10947872</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>158</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>To examine differences in perceptions about community stigma towards individuals with opioid use disorder (OUD) between community members involved in the opioid response (i.e., coalition members) and the general public, and how community geography may moderate this relationship.&lt;h4>Methods&lt;/h4>This study administered identical cross-sectional surveys about perceived community opioid-related stigma to two distinct populations in 66 communities participating in the HEALing Communities Study prior to the intervention period (i.e., coalition members, November 2019-January 2020; residents, March-April 2020). Linear-mixed models compared survey responses of populations, including the moderating effect of community rural/urban location.&lt;h4>Results&lt;/h4>A total of 826 coalition members and 1131 residents completed the surveys. The study found no differences between the coalition members and residents for general perceived community opioid-related stigma. In both urban and rural communities, coalition members reported greater perceived community stigma than residents reported towards medication for opioid use disorder (MOUD), naloxone, and drug treatment as an alternative to incarceration.&lt;h4>Conclusion&lt;/h4>Our findings suggest similar perceived community opioid-related stigma between coalition members and residents, yet differences emerge related to evidence-based practices (i.e., MOUD, naloxone, and drug treatment as an alternative to incarceration) to reduce opioid overdose deaths.&lt;h4>Trial registration&lt;/h4>ClinicalTrials.gov Identifier: NCT04111939.</pubmed_abstract><journal>Journal of substance use and addiction treatment</journal><pubmed_title>Differences in perceptions of community stigma towards opioid use disorder between community substance use coalition members and the general public.</pubmed_title><pmcid>PMC10947872</pmcid><funding_grant_id>UM1 DA049415</funding_grant_id><funding_grant_id>UM1 DA049412</funding_grant_id><funding_grant_id>Pro00038088</funding_grant_id><funding_grant_id>UM1 DA049394</funding_grant_id><funding_grant_id>UM1 DA049406</funding_grant_id><funding_grant_id>NCT04111939</funding_grant_id><funding_grant_id>UM1 DA049417</funding_grant_id><funding_grant_id>UM1DA049417</funding_grant_id><pubmed_authors>Oser CB</pubmed_authors><pubmed_authors>Lewis N</pubmed_authors><pubmed_authors>Shiu-Yee K</pubmed_authors><pubmed_authors>Holloway J</pubmed_authors><pubmed_authors>Balvanz P</pubmed_authors><pubmed_authors>Helme DW</pubmed_authors><pubmed_authors>Asman K</pubmed_authors><pubmed_authors>Oga EA</pubmed_authors><pubmed_authors>Davis A</pubmed_authors><pubmed_authors>Knudsen HK</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Jackson RD</pubmed_authors><pubmed_authors>Walker DM</pubmed_authors><pubmed_authors>Stotz C</pubmed_authors><pubmed_authors>Lefebvre RC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Differences in perceptions of community stigma towards opioid use disorder between community substance use coalition members and the general public.</name><description>&lt;h4>Introduction&lt;/h4>To examine differences in perceptions about community stigma towards individuals with opioid use disorder (OUD) between community members involved in the opioid response (i.e., coalition members) and the general public, and how community geography may moderate this relationship.&lt;h4>Methods&lt;/h4>This study administered identical cross-sectional surveys about perceived community opioid-related stigma to two distinct populations in 66 communities participating in the HEALing Communities Study prior to the intervention period (i.e., coalition members, November 2019-January 2020; residents, March-April 2020). Linear-mixed models compared survey responses of populations, including the moderating effect of community rural/urban location.&lt;h4>Results&lt;/h4>A total of 826 coalition members and 1131 residents completed the surveys. The study found no differences between the coalition members and residents for general perceived community opioid-related stigma. In both urban and rural communities, coalition members reported greater perceived community stigma than residents reported towards medication for opioid use disorder (MOUD), naloxone, and drug treatment as an alternative to incarceration.&lt;h4>Conclusion&lt;/h4>Our findings suggest similar perceived community opioid-related stigma between coalition members and residents, yet differences emerge related to evidence-based practices (i.e., MOUD, naloxone, and drug treatment as an alternative to incarceration) to reduce opioid overdose deaths.&lt;h4>Trial registration&lt;/h4>ClinicalTrials.gov Identifier: NCT04111939.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-06-02T00:00:10.369Z</modification><creation>2025-04-04T13:11:18.411Z</creation></dates><accession>S-EPMC10947872</accession><cross_references><pubmed>38142801</pubmed><doi>10.1016/j.josat.2023.209276</doi></cross_references></HashMap>